Brief: Nrx Pharmaceuticals Produces First Phase 3-Stage Nrx-101 Drug Made Using Commercial Process
09/11/2022 12:22
Nov 9 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS PRODUCES FIRST PHASE 3-STAGE NRX-101
DRUG
MADE USING COMMERCIAL PROCESS
* NRX PHARMACEUTICALS INC - MANUFACTURING FILES SUBMITTED TO
U.S.
FOOD AND DRUG ADMINISTRATION
* NRX PHARMACEUTICALS INC - NOW COMPLETED ITS TRANSITION TO
U.S.-BASED MANUFACTURING
Source text for Eikon: ID:nPn9Sb76pa
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview